Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDC42BPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PAIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2AK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERICH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SPON1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929078 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ELAVL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORCS3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC22A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOBOX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUNX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on